The mechanism works synergistically with other GHK-Cu effects

Patients taking Ozempic should contact their GP or diabetes care team if they experience any of the following: Persistent mouth sores lasting longer than three weeks without improvement (this requires urgent referral to exclude oral cancer, as per NICE guideline NG12) [3] Recurrent ulceration with multiple episodes occurring in quick succession Large or unusually painful ulcers that interfere with eating, drinking, or speaking Ulcers accompanied by systemic symptoms such as fever, fatigue, weight loss, or night sweats Red or white patches in the mouth that do not resolve (these may require urgent referral) Lumps or swellings in the mouth that persist (these may require urgent referral) Difficulty swallowing or a sensation of food sticking in the throat Signs of oral infection including white coating on the tongue (possible thrush), severe pain, or foul taste Red flag symptoms that require urgent medical attention include severe pain unresponsive to simple analgesia, signs of dehydration (reduced urine output, dizziness, confusion), or any suspicion of a serious underlying condition

Necroptosis in anti-viral inflammation
Charge accordingly
Making the LES close more tightly and keeping the acid in the stomach
Studies to clarify the riskbenefit ratio of DKA and improved cardio-renal outcomes with SGLT2i use in type 1 diabetes are required to help inform future guidelines and standardise clinical practice